1. Home
  2. CLPT

as of 02-04-2026 3:39pm EST

$13.27
$0.67
-4.84%
Stocks Health Care Medical/Dental Instruments Nasdaq

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

Founded: 1998 Country:
United States
United States
Employees: N/A City: SOLANA BEACH
Market Cap: 494.6M IPO Year: N/A
Target Price: $26.50 AVG Volume (30 days): 749.7K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.83 EPS Growth: N/A
52 Week Low/High: $9.76 - $30.10 Next Earning Date: 02-25-2026
Revenue: $34,332,000 Revenue Growth: 12.83%
Revenue Growth (this year): 18.93% Revenue Growth (next year): 51.64%

AI-Powered CLPT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 67.32%
67.32%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of ClearPoint Neuro Inc. (CLPT)

BURNETT JOSEPH MICHAEL

CEO and President

Sell
CLPT Jan 26, 2026

Avg Cost/Share

$15.57

Shares

2,943

Total Value

$45,822.51

Owned After

214,116

SEC Form 4

BURNETT JOSEPH MICHAEL

CEO and President

Sell
CLPT Jan 9, 2026

Avg Cost/Share

$16.12

Shares

20,000

Total Value

$322,400.00

Owned After

214,116

SEC Form 4

Share on Social Networks: